KDR and hepatocellular carcinoma: TUNEL assay revealed that increased anoikis by VEGFR2 inhibitor Axitinib or its blocking antibody was partially blunted by PAK1 activation with PAK1 T423E cotransfection in Klotho-overexpressed hepatoma cells (Figure 8C, 8F).